% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Cardoso:156950,
      author       = {R. Cardoso$^*$ and F. Guo$^*$ and T. Heisser$^*$ and M.
                      Hoffmeister$^*$ and H. Brenner$^*$},
      title        = {{U}tilisation of {C}olorectal {C}ancer {S}creening {T}ests
                      in {E}uropean {C}ountries by {T}ype of {S}creening {O}ffer:
                      {R}esults from the {E}uropean {H}ealth {I}nterview
                      {S}urvey.},
      journal      = {Cancers},
      volume       = {12},
      number       = {6},
      issn         = {2072-6694},
      address      = {Basel},
      publisher    = {MDPI},
      reportid     = {DKFZ-2020-01255},
      pages        = {1409},
      year         = {2020},
      note         = {#EA:C070#LA:C070#},
      abstract     = {In the past two decades, an extensive rollout of colorectal
                      cancer (CRC) screening programmes has been initiated in
                      European countries with a large heterogeneity of screening
                      offers. Using data from a population-based cross-sectional
                      survey conducted between 2013 and 2016 in all European Union
                      countries, we analysed the utilisation of faecal tests and
                      colonoscopy among people aged 50-74 years and the factors
                      associated with uptake by type of screening offer. We
                      observed the highest utilisation of either test for
                      countries with fully rolled out organised programmes with
                      faecal tests (ranging from $29.7\%$ in Croatia to $66.7\%$
                      in the UK) and countries offering both faecal tests and
                      colonoscopy (from $22.7\%$ in Greece to $70.9\%$ in
                      Germany). Utilisation was very low for countries with no
                      programme (from $6.3\%$ in Romania to $30.5\%$ in Norway).
                      Younger age (50-54 years), longer time since last
                      consultation with a doctor and a lifestyle score associated
                      with increased CRC risk were significantly associated with
                      lower test use, a pattern observed across all types of
                      screening offers. Our results suggest that more countries
                      should implement organised programmes with faecal
                      immunochemical tests, in combination with alternative
                      endoscopy offers where resources allow. Furthermore, there
                      is a large potential for increasing screening use in Europe
                      by better reaching the younger eligible individuals, those
                      who have not been to the doctor recently and those at
                      increased risk for CRC.},
      cin          = {C120 / C070 / HD01},
      ddc          = {610},
      cid          = {I:(DE-He78)C120-20160331 / I:(DE-He78)C070-20160331 /
                      I:(DE-He78)HD01-20160331},
      pnm          = {313 - Cancer risk factors and prevention (POF3-313)},
      pid          = {G:(DE-HGF)POF3-313},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:32486077},
      doi          = {10.3390/cancers12061409},
      url          = {https://inrepo02.dkfz.de/record/156950},
}